Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
04/19/1994 | CA1328613C Hypotensive agent comprising 4' ethyl-2-methyl-3-piperidinopropiophenone |
04/19/1994 | CA1328612C Cosmetic composition having an anti-cellulitis and slimming action in which the active ingredient is a 1-hydroxyalkyxanthin |
04/19/1994 | CA1328611C Pharmaceutical compositions comprising at least one aromatic compound as active principle |
04/19/1994 | CA1328610C Corticoid containing drug |
04/19/1994 | CA1328609C Antibiotic-polymer compositions |
04/19/1994 | CA1328608C Glaucoma treatment |
04/19/1994 | CA1328607C Method of improving post-ischemic myocardial dysfunction using thromboxane a_ antagonists |
04/19/1994 | CA1328606C Use of metformine in the preparation of drugs |
04/19/1994 | CA1328605C Medicinal composition useful for the treatment of dermatological diseases |
04/19/1994 | CA1328603C Method to prevent neonatal-jaundice |
04/14/1994 | WO1994008053A1 Oligonucleotides having a conserved g4 core sequence |
04/14/1994 | WO1994008041A1 Inhibition of cyst formation by cytoskeletal specific drugs |
04/14/1994 | WO1994008026A1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
04/14/1994 | WO1994008022A1 Vector to deliver and express foreign gene |
04/14/1994 | WO1994008008A1 Improvements in or relating to immune response modification |
04/14/1994 | WO1994008004A1 Therapeutic anti-hiv oligonucleotide and pharmaceutical |
04/14/1994 | WO1994008002A2 Methods and compositions for controlling translation of hcv proteins |
04/14/1994 | WO1994007909A1 NOVEL 17β-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME |
04/14/1994 | WO1994007905A1 2-substituted adenosines with a-2 receptor affinity |
04/14/1994 | WO1994007898A1 Novel cephalosporin derivatives and processes for the preparation thereof |
04/14/1994 | WO1994007896A1 Indole derivative, process for producing the same, and medicinal use thereof |
04/14/1994 | WO1994007893A1 DERIVATIVES OF 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM |
04/14/1994 | WO1994007892A1 Process for the preparation of 2-amino-6-chloropurine |
04/14/1994 | WO1994007890A1 Pyrimidine compound |
04/14/1994 | WO1994007883A1 Lithium salt of 2-o-alkylascorbic acid |
04/14/1994 | WO1994007881A1 Method of obtaining 10-deacetylbaccatine iii |
04/14/1994 | WO1994007879A1 Method of preparing taxane derivatives |
04/14/1994 | WO1994007878A1 Method of preparing taxane derivatives |
04/14/1994 | WO1994007877A1 Method of preparing taxane derivatives |
04/14/1994 | WO1994007875A1 Heterocyclic amines having colmodulin antagonist properties |
04/14/1994 | WO1994007874A1 Novel thiosemicarbazonethiones |
04/14/1994 | WO1994007873A1 Process for obtaining benzoxazines useful for the synthesis of ofloxacin, levofloxacin and derivatives thereof |
04/14/1994 | WO1994007870A1 1,2-dihydro-2-oxo-3-amino quinoxaline derivatives, preparation thereof and application in therapy |
04/14/1994 | WO1994007867A1 Substituted pyrimidines for control of diabetic complications |
04/14/1994 | WO1994007862A1 Unsymmetrically substituted bis-naphthalimides |
04/14/1994 | WO1994007859A1 5-ht4 antagonists |
04/14/1994 | WO1994007858A1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers |
04/14/1994 | WO1994007856A1 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract |
04/14/1994 | WO1994007853A1 25-carboxylic acid derivatives in the vitamin d series, method of producing them, intermediate products for this method, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines |
04/14/1994 | WO1994007852A1 Novel vitamin d analogues |
04/14/1994 | WO1994007851A1 Novel vitamin d analogues |
04/14/1994 | WO1994007846A1 Renin inhibiting n-(2-amino-2-oxoethyl)butanediamide derivatives |
04/14/1994 | WO1994007845A1 N-(hydroxyethyl)butanediamide derivatives as renin inhibitors |
04/14/1994 | WO1994007837A1 Unsaturated aliphatic dicarboxylic acids |
04/14/1994 | WO1994007830A1 A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
04/14/1994 | WO1994007541A1 Ibuprofen-h2 antagonist combinations |
04/14/1994 | WO1994007529A1 Therapeutic inhibitor of vascular smooth muscle cells |
04/14/1994 | WO1994007527A2 Vasoactive peptide inhibition |
04/14/1994 | WO1994007507A1 Method for antagonizing inositol 1,4,5-triphosphate |
04/14/1994 | WO1994007506A1 Calcium polycarbophil preparations which allow the active ingredient to be taken in large doses |
04/14/1994 | WO1994007505A1 Use of hyaluronic acid and forms to prevent arterial restenosis |
04/14/1994 | WO1994007504A1 New pharmaceutical formulations of spiramycine |
04/14/1994 | WO1994007503A1 Enteric preparations |
04/14/1994 | WO1994007501A1 Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents |
04/14/1994 | WO1994007500A1 2,5-dihydro-2,5-dioxo-1h-azepines and 2,5-dihydro-2-oxo-1h-azepines and the use thereof as excitatory amino acid and glycine receptor antagonists |
04/14/1994 | WO1994007498A1 Pharmaceutical composition for inhibiting tumor necrosis factor production |
04/14/1994 | WO1994007497A1 USE OF DOPAMINE AGONISTS TO ACTIVATE η-INTERFERON PRODUCTION |
04/14/1994 | WO1994007496A1 Tocolytic oxytocin receptor antagonists |
04/14/1994 | WO1994007495A1 Use of norastemizole for the treatment of allergic disorders |
04/14/1994 | WO1994007494A1 Oral compositions containing 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxyaldehyde-o-methyl-oxime |
04/14/1994 | WO1994007493A1 Stabilized compositions containing 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxyaldehyde-o-methyl-oxime |
04/14/1994 | WO1994007492A1 Use of 4-hydrazono-1,4-dihydro-pyridine and/or 4-hydrazino-pyridine derivatives for treatment of hypertension and congestive heart failure |
04/14/1994 | WO1994007491A1 Analgesic, anticonjunctivitic or chronic rheumatism remedy containing quinolizinone compound or salt thereof, and preparation for topical application thereof |
04/14/1994 | WO1994007490A1 Method and composition for the treatment of parkinson's disease |
04/14/1994 | WO1994007489A1 Non-competitive inhibitors of neuronal nicotinic acetylcholine receptors |
04/14/1994 | WO1994007488A1 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
04/14/1994 | WO1994007487A1 Use of melatonin to induce sleep |
04/14/1994 | WO1994007486A1 Benzo-fused lactams promote release of growth hormone |
04/14/1994 | WO1994007485A1 Zaragozic acid derivatives and methods of treating hypercholesterolemia, fungal growth, and cancer therewith |
04/14/1994 | WO1994007484A1 Pharmaceutical solutions and emulsions containing taxol |
04/14/1994 | WO1994007483A1 Benzo-fused lactams promote release of growth hormone |
04/14/1994 | WO1994007482A1 Prophylactic and remedy for cerebral edema |
04/14/1994 | WO1994007480A1 Polyamine derivatives as anti-cytomegaloviral agents |
04/14/1994 | WO1994007479A2 Immunopotentiatory agents |
04/14/1994 | WO1994007478A1 Topical pharmaceutical compositions |
04/14/1994 | WO1994007477A1 Taste masking of thymol |
04/14/1994 | WO1994007476A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
04/14/1994 | WO1994007475A1 Perfusion of perfluorocarbon compound emulsion during percutaneous transluminal angioplasty |
04/14/1994 | WO1994007474A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
04/14/1994 | WO1994007471A1 Ibuprofen-caffeine combinations |
04/14/1994 | WO1994007468A1 Two-phase matrix for sustained release drug delivery device |
04/14/1994 | WO1994007467A1 Calcium polycarbophil sprinkle |
04/14/1994 | WO1994007462A1 Cosmetic composition containing retinol |
04/14/1994 | WO1994007378A1 Food additive and use thereof |
04/14/1994 | WO1994004159A3 Treatment of cancer with azt and alkylating or intercalating agents |
04/14/1994 | WO1994002152A3 Phosphono derivatives as antiinflammatory and antiarthritic agents |
04/14/1994 | WO1994001095A3 Medicaments for the treatment of visceral pain and migraine |
04/14/1994 | WO1994000113A3 Medicaments containing 5-ht4 receptor antagonists |
04/14/1994 | WO1993024117A3 Medicaments for the treatment of anxiety |
04/14/1994 | DE4234130A1 Phospholipase A¶2¶ inhibierende Phosphatidylcholinverbindungen Phospholipase inhibitory A¶2¶ Phosphatidylcholinverbindungen |
04/14/1994 | DE4233963A1 Neue Benzopyranone, Verfahren zu ihrer Herstellung und Verwendung New benzopyranones, processes for their preparation and use |
04/14/1994 | CA2146545A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
04/14/1994 | CA2146462A1 1,2-dihydro-2-oxo-3-aminoquinoxalines; process for preparing the same and their use as therapeutic agents |
04/14/1994 | CA2146448A1 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
04/14/1994 | CA2146428A1 Use of dopamine agonists to activate -interferon production |
04/14/1994 | CA2146364A1 Therapeutic anti-hiv oligonucleotide and pharmaceutical |
04/14/1994 | CA2146333A1 Pyrimidine compound |
04/14/1994 | CA2146319A1 Polyamine derivatives as anti-cytomegaloviral agents |
04/14/1994 | CA2146251A1 New pharmaceutical spiramycin formulations |
04/14/1994 | CA2146249A1 Process for preparing taxane derivatives |